DNTH Dianthus Therapeutics, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $5.2B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $3.1M |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $1.5M | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $700.0K |
| 2025-Q4 | $0 | $8.3M |
| 2026-Q1 | $0 | $28.0M |
| 2026-Q2 | $0 | $5.6M |
| 2026-Q3 | $0 | $29.3M |
| 2026-Q4 | $0 | $11.2M |
Bought$1.5M7 buy days
Sold$86.2M29 sell days
Net insider flow-$84.7Mnet selling · 5 years
Latest trade2026-11-12Savitz Ryan
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-12 | Sell | Savitz Ryan | CFO | 17,724 | $90.56 | $1.6M | 1 |
| 2026-11-11 | Sell | Savitz Ryan | CFO | 3,044 | $90.03 | $274.1K | 1 |
| 2026-11-10 | Sell | Savitz Ryan | CFO | 2,561 | $90.14 | $230.8K | 1 |
| 2026-11-09 | Sell | Savitz Ryan | CFO | 100,713 | $90.54 | $9.1M | 6 |
| 2026-09-17 | Sell | CARR EDWARD | Other C-suite | 20,000 | $101.38 | $2.0M | 5 |
| 2026-09-01 | Sell | Randhawa Simrat | EVP / SVP | 23,124 | $106.41 | $2.5M | 3 |
| 2026-08-19 | Sell | Read Simon | Director | 2,778 | $117.55 | $326.6K | 1 |
| 2026-08-10 | Sell | Veness Adam M | General counsel | 16,167 | $110.38 | $1.8M | 1 |
| 2026-08-10 | Sell | McGeorge Anne | Director | 7,750 | $109.01 | $844.8K | 5 |
| 2026-08-10 | Sell | Read Simon | Director | 2,777 | $109.55 | $304.2K | 6 |
| 2026-08-07 | Sell | Garcia Marino | CEO | 166,000 | $108.11 | $17.9M | 7 |
| 2026-08-07 | Sell | Veness Adam M | General counsel | 3,833 | $110.70 | $424.3K | 2 |
| 2026-07-09 | Sell | Savitz Ryan | CFO | 31,249 | $101.03 | $3.2M | 3 |
| 2026-06-17 | Sell | Veness Adam M | General counsel | 30,000 | $80.80 | $2.4M | 2 |
| 2026-06-01 | Sell | Randhawa Simrat | EVP / SVP | 26,530 | $90.62 | $2.4M | 3 |
| 2026-05-08 | Sell | Soteropoulos Paula | Director | 599 | $85.47 | $51.2K | 1 |
| 2026-04-09 | Sell | Savitz Ryan | CFO | 8,224 | $89.84 | $738.8K | 1 |
| 2026-03-31 | Sell | Savitz Ryan | CFO | 114,367 | $83.00 | $9.5M | 8 |
| 2026-03-31 | Sell | Soteropoulos Paula | Director | 599 | $80.11 | $48.0K | 1 |
| 2026-03-24 | Sell | Soteropoulos Paula | Director | 27,594 | $78.05 | $2.2M | 1 |
| 2026-03-12 | Sell | Garcia Marino | CEO | 122,918 | $81.49 | $10.0M | 5 |
| 2026-03-12 | Sell | CARR EDWARD | Other C-suite | 43,682 | $81.49 | $3.6M | 5 |
| 2026-03-12 | Sell | Randhawa Simrat | EVP / SVP | 33,830 | $81.48 | $2.8M | 1 |
| 2025-12-04 | Sell | Savitz Ryan | CFO | 20,000 | $45.18 | $903.6K | 1 |
| 2025-11-14 | Sell | Randhawa Simrat | EVP / SVP | 109,031 | $38.14 | $4.2M | 1 |
| 2025-11-13 | Sell | Randhawa Simrat | EVP / SVP | 87,507 | $36.81 | $3.2M | 3 |
| 2025-09-09 | Sell | Savitz Ryan | CFO | 20,000 | $35.00 | $700.0K | 1 |
| 2023-09-29 | Buy | Harwin Peter Evan | Director | 24,670 | $13.63 | $336.3K | 1 |
| 2023-09-26 | Buy | Harwin Peter Evan | Director | 30,000 | $13.15 | $394.5K | 1 |
| 2023-09-22 | Buy | Randhawa Simrat | Other C-suite | 2,000 | $13.20 | $26.4K | 1 |
| 2023-09-21 | Buy | Randhawa Simrat | Other C-suite | 2,000 | $13.20 | $26.4K | 1 |
| 2023-09-19 | Buy | Harwin Peter Evan | Director | 30,000 | $13.20 | $396.0K | 1 |
| 2023-09-13 | Buy | Harwin Peter Evan | Director | 9,367 | $11.76 | $110.2K | 1 |
| 2023-09-12 | Buy | Harwin Peter Evan | Director | 14,887 | $10.85 | $161.5K | 1 |
| 2023-02-08 | Sell | TRV GP IV, LLC | 10% owner | 1,500,000 | $0.82 | $1.2M | 1 |
| 2023-02-07 | Sell | TRV GP IV, LLC | 10% owner | 2,200,000 | $0.83 | $1.8M | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Garcia Marino | CEO | $0 | $28.0M | 2026-08-07 |
| Savitz Ryan | CFO | $0 | $26.2M | 2026-11-12 |
| Randhawa Simrat | EVP / SVP | $52.8K | $15.0M | 2026-09-01 |
| CARR EDWARD | Other C-suite | $0 | $5.6M | 2026-09-17 |
| Veness Adam M | General counsel | $0 | $4.6M | 2026-08-10 |
| TRV GP IV, LLC | 10% owner | $0 | $3.1M | 2023-02-08 |
| Soteropoulos Paula | Director | $0 | $2.3M | 2026-05-08 |
| Harwin Peter Evan | Director | $1.4M | $0 | 2023-09-29 |
| McGeorge Anne | Director | $0 | $844.8K | 2026-08-10 |
| Read Simon | Director | $0 | $630.8K | 2026-08-19 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.